Why the Slater & Gordon Limited share price is sinking again

Slater & Gordon Limited (ASX:SGH) looks just about the opposite of a good investment.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Things aren't getting any better for investors in Slater & Gordon Limited (ASX: SGH) with the shares down 2% to 9.5 cents on Friday afternoon and down 28% over the past month.

The share price has been sliding over the last month after the law firm announced most of its giant debt pile had been sold on by creditor banks such as Westpac Banking Corp (ASX: WBC) and National Australia Bank Ltd (ASX: NAB) to distressed debt and private capital specialists mainly headquartered in the US.

As a result the company's new senior lenders have reportedly agreed to allow Slater & Gordon "to incur new senior debt of up to $40 million from one or more of the new senior lenders" under the terms of a re-negotiated syndicated senior lending facility.

At the time of the most recent announcement on March 28 the personal injury law firm also advised the market that: "The Company expects that discussion with its New Senior Lenders will be successfully concluded in the next few weeks, at which time a further announcement to the market will be made".

More than four weeks later, Slater & Gordon has yet to provide an update to the market as to its route forward as a going concern and investors are getting nervous as to the road ahead.

That's not surprising given that the company's debt to equity ratio as it stands is unworkable, with a general expectation that any new deal which sees its new creditors write off some debt in exchange for new equity could leave current shareholders all but wiped out.

As such I would suggest investors steer well clear of Slater & Gordon shares and if I were a shareholder I would probably look to take what I can get now. Of course only time will tell, but given its debt mountain and operating performance it looks like there could be more pain ahead for Slater & Gordon's unfortunate shareholders.

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »